 |
Articles: Cardiac/Hypertension |
Prior Articles
Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data
Pharmacoepidemiology and Drug Safety, 10/27/09
Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrillation
Evidence-Based Medicine, 10/26/09
Evidence Based Medicine
Sub-lethal doses of an anti-erbB2 antibody leads to death by apoptosis in cardiomyocytes sensitized by low pro-senescent doses of epirubicin: the protective role of dexrazoxane
Journal of Pharmacology and Experimental Therapeutics, 10/26/09 Lipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the Elderly: Opportunities and Challenges
Drugs & Aging, 10/26/09 Randomized study to compare valsartan ± HCTZ versus amlodipine ± HCTZ strategies to maximize blood pressure control
Vascular Health and Risk Management, 10/23/09
Free full text
Inflammatory Systemic Biomarkers in Setting Acute Coronary Syndromes - Effects of the Diurnal Variation
Current Drug Targets, 10/23/09 Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension
Clinical Therapeutics, 10/23/09 Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Vascular Health and Risk Management, 10/22/09
Free full text
Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice
Current Medical Research and Opinion, 10/22/09
Evidence Based Medicine
Renal protective effect of RAAS blockade across the renal continuum, with a review of the efficacy and safety of valsartan
Current Medical Research and Opinion, 10/22/09
Revew Article
FDA Issues Complete Response Letter for Corvue
King Pharmaceuticals, 10/22/09
Free full text
Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease
Annals of Internal Medicine, 10/20/09
Free full text
Evidence Based Medicine
Revew Article
Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery
Cochrane Reviews, 10/20/09 FDA approves Micardis as the first treatment in its class to reduce the risk of heart attack, stroke, or death from cardiovascular causes in patients at high cardiovascular risk who are unable to take ACE inhibitors
Boehringer Ingelheim, 10/20/09
Free full text
FDA approves Twynsta a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours
Boehringer Ingelheim, 10/20/09
Free full text
Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study
Journal of Cardiovascular Pharmacology, 10/19/09 C-Reactive Protein Gene Variant and the Human Left Ventricular Growth Response to Exercise: Data from the LARGE Heart Study
Journal of Cardiovascular Pharmacology, 10/19/09 Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers
Clinical Therapeutics, 10/15/09
Evidence Based Medicine
Early Intervention of Tyrosine Nitration Prevents Vaso-obliteration and Neovascularization in Ischemic Retinopathy
Journal of Pharmacology and Experimental Therapeutics, 10/14/09 Use of Combination Therapy with a beta-Blocker and Milrinone in Patients with Advanced Heart Failure
Annals of Pharmacotherapy, 10/13/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
